ASTRO 2018: MGMT Protein Expression Helps Stratify Prognoses of Survival of Unmethylated Glioblastoma.
MGMT protein expression has been shown to be an independent prognostic biomarker of newly diagnosed glioblastomas. The immunohistochemistry test may identify, upfront and at lower cost, patients who may not respond to the Stupp protocol. This finding of a retrospective analysis was reported at the 60th Annual Meeting of the American Society for Radiation Oncology […]
